REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma

202297 citationsJournal Articlehybrid Open Access

Authors

Charles Pilette · Cliniques Universitaires Saint-Luc

Giorgio Walter Canonica · Humanitas University

Rekha Chaudhuri · Gartnavel General Hospital

Geoffrey Chupp · Yale University

F. Eun‐Hyung Lee · Emory University

Jason Kihyuk Lee

Carlos Almonacid · Hospital Universitario Ramón y Cajal

Abstract

This 1-year analysis demonstrates that real-world mepolizumab treatment is clinically effective in patients with severe asthma, providing disease control while reducing the need for mOCS and SCS bursts.

Topics & Keywords

Asthma and respiratory diseases Respiratory and Cough-Related Research Allergic Rhinitis and Sensitization

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Journal of Allergy and Clinical Immunology In Practice

Volume 10, Issue 10, pp. 2646-2656

DOI: 10.1016/j.jaip.2022.05.042

Field-Weighted Citation Impact: 10.97